5,164 reports of this reaction
1.5% of all CETIRIZINE HYDROCHLORIDE TABLETS reports
#18 most reported adverse reaction
WOUND is the #18 most commonly reported adverse reaction for CETIRIZINE HYDROCHLORIDE TABLETS, manufactured by Dr. Reddy's Laboratories Inc.. There are 5,164 FDA adverse event reports linking CETIRIZINE HYDROCHLORIDE TABLETS to WOUND. This represents approximately 1.5% of all 341,923 adverse event reports for this drug.
Patients taking CETIRIZINE HYDROCHLORIDE TABLETS who experience wound should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WOUND is a less commonly reported adverse event for CETIRIZINE HYDROCHLORIDE TABLETS, but still significant enough to appear in the safety profile.
In addition to wound, the following adverse reactions have been reported for CETIRIZINE HYDROCHLORIDE TABLETS:
The following drugs have also been linked to wound in FDA adverse event reports:
WOUND has been reported as an adverse event in 5,164 FDA reports for CETIRIZINE HYDROCHLORIDE TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
WOUND accounts for approximately 1.5% of all adverse event reports for CETIRIZINE HYDROCHLORIDE TABLETS, making it a notable side effect.
If you experience wound while taking CETIRIZINE HYDROCHLORIDE TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.